<?xml version="1.0" encoding="UTF-8"?>
<p>The scale of the HCV epidemic demands national ownership of elimination programs, including strong financial commitment. Treatment of all patients with chronic HCV has been shown to not only be cost-effective, but cost-saving in the long run as an earlier intervention prevents the development of cirrhosis [
 <xref rid="R9" ref-type="bibr">9</xref>]. Others can learn from Egypt, the country with the world's largest HCV disease burden. The problem has been a high priority for national government and the country is making remarkable progress in reaching the WHO elimination goals through driving down drug prices, optimizing procurement processes, improving infection control and blood safety, introducing mass education programs, improving community engagement, and implementing widespread testing with linkage to free treatment and follow-up care [
 <xref rid="R10" ref-type="bibr">10</xref>].
</p>
